Zhang, X., Thakur, R. K., Mariampillai, A. I., Xiao, N., Song, J., Li, Y., Nai, Q. (2026). Does BMA improve outcomes in mHSPC with bone metastases?: Landmark propensity-matched analysis and nested zoledronic acid vs denosumab.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e17100